Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01132053 · ClinicalTrials.gov registry record
Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
A clinical trial, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- 126
- Enrollment target
NCT01132053 is a clinical trial that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 126 participants.
The verdict
NCT01132053 has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2004-06 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01132053
The ClinicalTrials.gov registry entry for NCT01132053 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01132053 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01132053 about?
NCT01132053 is a clinical study titled "Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)". This is a continuation of our previous studies on Progressive Multifocal Leukoencephalopathy (PML). We will focus on the role of inflammation in PML, and define prognostic markers of disease evolution.
What is the current status of trial NCT01132053?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2004-06. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01132053?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.